Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.
Shingo KomuraKenji ItoSho OhtaTomoyo UkaiMio KabataFumiaki ItakuraKatsunori SemiYutaka MatsudaKyoichi HashimotoHirofumi ShibataMasamitsu SoneNorihide JoKazuya SekiguchiTakatoshi OhnoHaruhiko AkiyamaKatsuji ShimizuKnut WoltjenManabu OzawaJunya ToguchidaTakuya YamamotoYasuhiro YamadaPublished in: Nature communications (2019)
Clear cell sarcoma (CCS) is a rare soft tissue sarcoma caused by the EWS/ATF1 fusion gene. Here, we established induced pluripotent stem cells (iPSCs) from EWS/ATF1-controllable murine CCS cells harboring sarcoma-associated genetic abnormalities. Sarcoma-iPSC mice develop secondary sarcomas immediately after EWS/ATF1 induction, but only in soft tissue. EWS/ATF1 expression induces oncogene-induced senescence in most cell types in sarcoma-iPSC mice but prevents it in sarcoma cells. We identify Tppp3-expressing cells in peripheral nerves as a cell-of-origin for these sarcomas. We show cell type-specific recruitment of EWS/ATF1 to enhancer regions in CCS cells. Finally, epigenetic silencing at these enhancers induces senescence and inhibits CCS cell growth through altered EWS/ATF1 binding. Together, we propose that distinct responses to premature senescence are the basis for the cell type-specificity of cancer development.
Keyphrases
- induced apoptosis
- endoplasmic reticulum stress
- transcription factor
- cell cycle arrest
- induced pluripotent stem cells
- dna damage
- clear cell
- single cell
- endothelial cells
- signaling pathway
- oxidative stress
- gene expression
- poor prognosis
- genome wide
- squamous cell carcinoma
- high fat diet induced
- dna binding
- mouse model
- long non coding rna
- skeletal muscle